0

CDNF human

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATIAR4248814
Descriptionrecombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture
Assay≥98% (HPLC); ≥98% (SDS-PAGE)
Colorwhite to off-white
Formlyophilized
Impurity Content<0.1 EU/μg endotoxin, tested
Size25μG
Storage Conditions−20°C
1

CDNF Protein Therapy in Parkinson's Disease

Henri J Huttunen, Mart Saarma

Cell Transplant. 2019 Apr;28(4):349-366.

PMID: 30947516

1

Cerebral Dopamine Neurotrophic Factor Diffuses Around the Brainstem and Does Not Undergo Anterograde Transport After Injection to the Substantia Nigra

Katrina Albert, Juho-Matti Renko, Kert Mätlik, Mikko Airavaara, Merja H Voutilainen

Front Neurosci. 2019 Jun 11;13:590.

PMID: 31244598

1

Gene Therapy for Parkinson's Disease, An Update

Tobias M Axelsen, David P D Woldbye

J Parkinsons Dis. 2018;8(2):195-215.

PMID: 29710735

1

Increased Serum Levels of Mesencephalic Astrocyte-Derived Neurotrophic Factor in Subjects With Parkinson's Disease

Emilia Galli, Anu Planken, Liis Kadastik-Eerme, Mart Saarma, Pille Taba, Päivi Lindholm

Front Neurosci. 2019 Sep 4;13:929.

PMID: 31555085

1

Transient Transfection of Human CDNF Gene Reduces the 6-hydroxydopamine-induced Neuroinflammation in the Rat Substantia Nigra

Rasajna Nadella, Merja H Voutilainen, Mart Saarma, Juan A Gonzalez-Barrios, Bertha A Leon-Chavez, Judith M Dueñas Jiménez, Sergio H Dueñas Jiménez, Lourdes Escobedo, Daniel Martinez-Fong

J Neuroinflammation. 2014 Dec 16;11:209.

PMID: 25511018

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode